Mri Scan: Clinical Trials

290 recruiting, 217 active not recruiting, 90 completed, 44 withdrawn. 356 Phase 2, 191 Phase 1, 112 Not applicable, 105 Phase 3, 23 Early Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	356	Recruiting 142, Active not recruiting 122, Not yet recruiting 24, Withdrawn 22, Completed 19, Suspended 13, Terminated 13, Enrolling by invitation 1
Phase 1	191	Recruiting 80, Active not recruiting 52, Suspended 13, Terminated 13, Not yet recruiting 11, Withdrawn 11, Completed 10, Unknown 1
Not applicable	112	Completed 31, Recruiting 28, Active not recruiting 14, Unknown 14, Terminated 11, Withdrawn 9, Not yet recruiting 5
Phase 3	105	Recruiting 46, Active not recruiting 39, Not yet recruiting 7, Completed 5, Suspended 5, Terminated 3
Early Phase 1	23	Recruiting 9, Completed 6, Active not recruiting 4, Terminated 3, Withdrawn 1
Phase 4	7	Recruiting 4, Completed 2, Enrolling by invitation 1

Follow Mri Scan: new trials by email Literature Review of Mri Scan trials Research Report on Mri Scan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial Biospecimen Collection, Cisplatin, Computed Tomography - Resectable Intrahepatic Cholangiocarcinoma	Phase 2	Not yet recruiting	Northwestern University	44	2027-12-10	2026-06-10
Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Biospecimen Collection, Computed Tomography, Futibatinib - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8	Phase 1	Not yet recruiting	Northwestern University	18	2027-09-09	2026-10-20
Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Phase 2	Not yet recruiting	City of Hope Medical Center	44	2027-08-04	2026-09-10
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography - Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma	Phase 1 / Phase 2	Recruiting	National Cancer Institute (NCI)	76	2027-06-25	2026-10-22
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer Biospecimen Collection, Carboplatin, Computed Tomography - Lung Non-Squamous Non-Small Cell Carcinoma	Phase 2	Not yet recruiting	Jonsson Comprehensive Cancer Center	16	2027-06-01	2026-02-05
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8	Phase 2	Recruiting	Children's Oncology Group	51	2027-05-15	2026-09-24
CCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver	Phase 1	Not yet recruiting	City of Hope Medical Center	36	2027-05-06	2026-09-25
Enfortumab Vedotin for the Treatment of Unresectable or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer, or NUT Carcinoma Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Differentiated Thyroid Gland Carcinoma, Metastatic NUT Carcinoma	Phase 2	Not yet recruiting	Northwestern University	56	2027-05-05	2026-10-07
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Plasma Cell Leukemia	Phase 2	Recruiting	National Cancer Institute (NCI)	74	2027-04-20	2026-10-07
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma	Phase 1	Not yet recruiting	City of Hope Medical Center	16	2027-04-17	2026-08-11
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma	Phase 3	Recruiting	SWOG Cancer Research Network	562	2027-03-09	2026-10-13
FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma Biospecimen Collection, Computed Tomography, Dexamethasone - Glioblastoma, Malignant Glioma	Phase 1	Not yet recruiting	City of Hope Medical Center	24	2027-02-17	2026-08-27
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor	Phase 2	Not yet recruiting	Joal Beane	59	2027-02-15	2026-10-13
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma Biospecimen Collection, Bone Scan, Computed Tomography - Non-Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8	Phase 3	Not yet recruiting	National Cancer Institute (NCI)	400	2027-02-10	2026-07-08
SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial Biospecimen Collection, Computed Tomography, Electronic Health Record Review - Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma	Phase 2	Not yet recruiting	Northwestern University	125	2027-02-03	2026-08-06
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer Biospecimen Collection, Cisplatin, Computed Tomography - Locally Advanced Biliary Tract Adenocarcinoma, Locally Advanced Extrahepatic Cholangiocarcinoma	Phase 2 / Phase 3	Not yet recruiting	ECOG-ACRIN Cancer Research Group	336	2027-01-11	2026-08-14
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8	Phase 2 / Phase 3	Not yet recruiting	ECOG-ACRIN Cancer Research Group	432	2027-01-06	2026-10-01
Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Prostate Cancer Biopsy Procedure, Computed Tomography, Electronic Health Record Review - Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8	Not applicable	Not yet recruiting	City of Hope Medical Center	20	2027-01-01	2026-08-17
Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial Biopsy Procedure, Biospecimen Collection, Bone Scan - Advanced Hormone Receptor-Positive Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8	Phase 1	Not yet recruiting	City of Hope Medical Center	20	2026-12-19	2026-05-15
Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung Cancer Biospecimen Collection, Computed Tomography, Immunotherapy - Locally Recurrent Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8	Phase 2	Not yet recruiting	NRG Oncology	138	2026-12-18	2026-09-23

Showing 20 of 777. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (64)  ·  Lung Neoplasms (53)  ·  Carcinoma, Non-Small-Cell Lung (40)  ·  Neoplasm Metastasis (40)  ·  Glioblastoma (39)  ·  Breast Neoplasms (33)  ·  Glioma (32)  ·  Brain Neoplasms (31)  ·  Pancreatic Neoplasms (30)  ·  Carcinoma, Renal Cell (29)  ·  Melanoma (25)  ·  Multiple Myeloma (25)  ·  Ovarian Neoplasms (25)  ·  Colorectal Neoplasms (24)  ·  Urinary Bladder Neoplasms (23)

Sponsors

National Cancer Institute (NCI) (239)  ·  Mayo Clinic (84)  ·  City of Hope Medical Center (45)  ·  M.D. Anderson Cancer Center (35)  ·  Children's Oncology Group (28)  ·  NRG Oncology (25)  ·  Jonsson Comprehensive Cancer Center (20)  ·  OHSU Knight Cancer Institute (17)  ·  Emory University (16)  ·  Roswell Park Cancer Institute (15)  ·  Northwestern University (14)  ·  SWOG Cancer Research Network (14)  ·  University of Washington (13)  ·  ECOG-ACRIN Cancer Research Group (12)  ·  University of Southern California (11)

Countries

United States (677)  ·  Canada (87)  ·  Puerto Rico (50)  ·  Australia (31)  ·  United Kingdom (27)  ·  New Zealand (13)  ·  France (8)  ·  Hong Kong (8)  ·  Guam (7)  ·  Saudi Arabia (7)  ·  Germany (6)  ·  Israel (6)  ·  South Korea (6)  ·  China (5)  ·  Japan (5)

Top investigators

Andrea B Apolo (4)  ·  Haider S Mahdi (4)  ·  Joyce F Liu (4)  ·  Roman O. Kowalchuk, MD (4)  ·  Terence C. Burns, MD, PhD (4)  ·  A P Chen (3)  ·  Andrei Iagaru (3)  ·  Behnam Badie (3)  ·  Funda Meric-Bernstam (3)  ·  Ibrahim Aldoss (3)  ·  Jacob J. Orme, MD, PhD (3)  ·  Marwan G Fakih (3)  ·  Matthew S. Block, MD, PhD (3)  ·  Nilofer S Azad (3)  ·  Patricia M LoRusso (3)

Results publications

PMID 37505794, PMID 31401903, PMID 33395032, PMID 35031545, PMID 37185961, PMID 37222189, PMID 38421243, PMID 39571596, PMID 23810467, PMID 25218906, PMID 26586415, PMID 26659347, PMID 27185374, PMID 27811504, PMID 27916710, PMID 28029927, PMID 28079169, PMID 28223062, PMID 29211618, PMID 29223478, PMID 29270800, PMID 29326651, PMID 29358426, PMID 29376112, PMID 29902200, PMID 30126352, PMID 30231854, PMID 30332335, PMID 30653209, PMID 31279240, PMID 31449468, PMID 31723837, PMID 31969335, PMID 32463741, PMID 32597469, PMID 32915679, PMID 32920242, PMID 33048619, PMID 33067126, PMID 33067273, PMID 33084020, PMID 33152282, PMID 33362722, PMID 33370024, PMID 33591402, PMID 33604999, PMID 33641042, PMID 33843815, PMID 33878954, PMID 33882143

NIH funding

P30CA033572 (47), U10CA180868 (47), U10CA180820 (46), U10CA180886 (42), U10CA180821 (33), U10CA180888 (33), P30CA060553 (22), P30CA138292 (15), UM1CA186689 (15), UM1CA186709 (15), UM1CA186691 (12), P30CA014089 (11), UM1CA186644 (10), UM1CA186690 (10), UM1CA186712 (10)